Cellosaurus logo
expasy logo

Cellosaurus KE-6 (CVCL_WK77)

[Text version]
Cell line name KE-6
Synonyms KE6
Accession CVCL_WK77
Resource Identification Initiative To cite this cell line use: KE-6 (RRID:CVCL_WK77)
Comments Population: Japanese.
Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
Disease Esophageal squamous cell carcinoma (NCIt: C4024)
Squamous cell carcinoma of the esophagus (ORDO: Orphanet_99977)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
STR profile Source(s): JCRB=JCRB1915

Markers:
AmelogeninX
CSF1PO10,11
D5S81813
D7S82011
D13S31711
D16S5399,13
TH016
TPOX8,11
vWA16,17

Run an STR similarity search on this cell line
Publications

PubMed=14532970; DOI=10.3892/ijo.23.5.1309
Matono S., Tanaka T., Sueyoshi S., Yamana H., Fujita H., Shirouzu K.
Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer.
Int. J. Oncol. 23:1309-1315(2003)

PubMed=20515944; DOI=10.1158/1535-7163.MCT-09-0918; PMCID=PMC2884061
Seki N., Toh U., Sayers T.J., Fujii T., Miyagi M., Akagi Y., Kusukawa J., Kage M., Shirouzu K., Yamana H.
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Mol. Cancer Ther. 9:1842-1851(2010)

PubMed=26512696; DOI=10.3390/cancers7040881; PMCID=PMC4695881
O'Callaghan C., Fanning L.J., Barry O.P.
Hypermethylation of MAPK13 promoter in oesophageal squamous cell carcinoma is associated with loss of p38delta MAPK expression.
Cancers (Basel) 7:2124-2133(2015)

Cross-references
Cell line collections (Providers) JCRB; JCRB1915
Encyclopedic resources Wikidata; Q94338022
Entry history
Entry creation24-May-2019
Last entry update02-May-2024
Version number7